Core Laboratories (CLB) Capital Expenditures (2022 - 2026)

Core Laboratories has reported Capital Expenditures for 5 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 46.79% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $9.9 million (down 26.48% YoY), and the FY2025 full-year result was $11.2 million, down 5.71% from the prior year.
• Capital Expenditures for Q1 2026 stood at $1.5 million, down from $2.9 million in the prior quarter.
• The five-year high for Capital Expenditures was $7.4 million in Q3 2025, with the low at -$7.0 million in Q4 2022.
• Historically, Capital Expenditures has averaged $1.8 million across 5 years, with a median of $2.7 million in 2022.
• Annual changes were most pronounced in 2024 — Capital Expenditures surged 4364.47% — and 2025, when it slumped 141.67%.
• Core Laboratories' Capital Expenditures stood at -$7.0 million in 2022, then jumped by 98.92% to -$76000.0 in 2023, then surged by 4364.47% to $3.2 million in 2024, then declined by 9.16% to $2.9 million in 2025, then plunged by 49.66% to $1.5 million in 2026.
• The last three Capital Expenditures figures came in at $1.5 million (Q1 2026), $2.9 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.